You are here

  • Home
  • Archive
  • Volume 73, Issue 11
  • Targeted treatment with a combination of traditional DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of a randomised clinical trial, the N…

Article info

Article menu
Download PDFPDF
Clinical and epidemiological research
Extended report
Targeted treatment with a combination of traditional DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of a randomised clinical trial, the NEO-RACo trial

Authors

  1. Correspondence to Dr Vappu Rantalaiho, Department of Internal Medicine, Centre for Rheumatic Diseases, Tampere University Hospital, Central Hospital, PO BOX 2000, Tampere FI-33521, Finland; vappu.rantalaiho{at}pshp.fi
View Full Text

Citation

Rantalaiho V, Kautiainen H, Korpela M for the NEO-RACo Study Group, et al
Targeted treatment with a combination of traditional DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of a randomised clinical trial, the NEO-RACo trial
Annals of the Rheumatic Diseases 2014;73:1954-1961.

Publication history

  • Received February 20, 2013
  • Revised June 16, 2013
  • Accepted July 9, 2013
  • First published August 1, 2013.
Online issue publication 
October 25, 2017

Article Versions

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions